Analytics

Equity Analytics

Equity Analytics/IPN.PA

IPN.PA

Ipsen S.A.

Healthcare - FR

Ipsen S.A. is a global biopharmaceutical company specializing in the research, development, manufacture, and commercialization of innovative medicines primarily in the fields of oncology, neuroscience, and rare diseases. The company's core…

HQ: Paris, IF, Francewww.ipsen.com

EUR166.40-0.36%vs prev. close

Performance

+4.85%

+14.29%

+6.67%

+27.31%

YTD

+39.83%

Valuation

P/E

27.0

EPS TTM

6.17

Dividend yield

0.96%

Size and risk

Market cap

$15.2B

Beta

0.32

Next earnings

Report date

EPS estimate

Revenue estimate

Peer comparison

Ipsen
IPN.PA
Drug Manufacturers - Specialty & Generic
Mkt cap (USD bn)
15.2
P/E
27.0
Div yld
0.96%
1W
+4.8%
1M
+14.3%
3M
+6.7%
6M
+0.2%
1Y
+27.3%
YTD
+39.8%

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Ipsen	IPN.PA	Drug Manufacturers - Specialty & Generic	15.2	27.0	0.96%	+4.8%	+14.3%	+6.7%	+0.2%	+27.3%	+39.8%

Subscribe to Equity Analytics to compare IPN.PA with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

Ask, then keep asking: it follows the conversation for 30 minutes, grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.

Equity Analytics

IPN.PA

Price history

Next earnings

Peer comparison

Equity Analytics

IPN.PA

Price history

Next earnings

Peer comparison